Sodium Nitroprusside (Nexus Pharmaceuticals Inc)
Welcome to the PulseAid listing for the Sodium Nitroprusside drug offered from Nexus Pharmaceuticals Inc. This Vasodilation [PE],Vasodilator [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Nexus Pharmaceuticals Inc |
| NON-PROPRIETARY NAME: | Sodium Nitroprusside |
| SUBSTANCE NAME: | SODIUM NITROPRUSSIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Vasodilation [PE],Vasodilator [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-05-29 |
| END MARKETING DATE: | 0000-00-00 |
Sodium Nitroprusside HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sodium Nitroprusside from Nexus Pharmaceuticals Inc |
| LABELER NAME: | Nexus Pharmaceuticals Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/mL) |
| START MARKETING DATE: | 2017-05-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 14789-012_3718a55c-6a17-478e-a41d-8f605d9534ca |
| PRODUCT NDC: | 14789-012 |
| APPLICATION NUMBER: | ANDA207499 |
Other SODIUM NITROPRUSSIDE Pharmaceutical Manufacturers / Labelers:
